Skip to content
MedCompare

Arformoterol

Asthma & Respiratory
Save $88/mo
12× cheaper

Arformoterol Tartrate Inhalation Solution is a long-acting beta 2 -adrenergic agonist (beta 2 -agonist) indicated for: Long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

United States
$97
per month
India
$8
per month
You save
−91%
save $88/mo · 91% cheaper
20.5K US scripts/yr$1.8M potential annual savings$2M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC19H24N2O4

SMILES: C[C@H](CC1=CC=C(C=C1)OC)NC[C@@H](C2=CC(=C(C=C2)O)NC=O)O

Compare the price
US price$97per month
India price$8per month
You save$8891% less

Based on 30 units per month. US $3.22 vs India $0.27 per unit.

Total over 1 periodSave $88$97 → $8
The bigger picture

Arformoterol is filled about 20.5K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$2M
If sourced from India
$168.5K
Potential annual savings
$1.8M
−91%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.